# Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout Flare

> **NCT03933007** · PHASE4 · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 26 (actual)

## Conditions studied

- Gout Flare

## Interventions

- **DRUG:** Colchicine,
- **DRUG:** midazolam,
- **DRUG:** fexofenadine

## Key facts

- **NCT ID:** NCT03933007
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-10
- **Primary completion:** 2019-10-10
- **Final completion:** 2024-02-28
- **Target enrollment:** 26 (ACTUAL)
- **Why stopped:** faillure of recrutement
- **Last updated:** 2024-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03933007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03933007, "Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout Flare". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03933007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*